Sahajanand Medical Technologies IPO
Open now, until 19 Oct 2026. Price band ₹327 to ₹344, minimum ₹14,792.
About Sahajanand Medical Technologies
Sahajanand Medical Technologies develops and makes cardiovascular implants such as coronary stents, balloons, TAVI heart valve systems and occluders, and sells them in India and abroad.
Entirely an offer for sale by promoter and investor shareholders, including Shree Hari Trust, Samara Capital Markets Holding, Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding; the company receives no money.
Important dates
- Wed, 14 OctAnchor investors
- Thu, 15 OctOpens
- Mon, 19 OctCloses
- Wed, 21 OctAllotment
- Thu, 22 OctRefunds or unblocking
- Thu, 22 OctShares in demat
- Fri, 23 OctListing
Issue details
| Price band | ₹327 to ₹344 per share |
|---|---|
| Lot size | 43 shares |
| Minimum investment | ₹14,792 (one lot at the upper band) |
| Issue size | ₹475.48 crore |
| Fresh issue | None |
| Offer for sale | ₹475.48 crore |
| Face value | ₹1 per share |
| Reservation | QIB 50%, NII 15%, retail 35% |
| Anchor investors raised | ₹140.06 crore |
| Listing on | NSE and BSE |
| Registrar | MUFG Intime India |
| Lead managers | Motilal Oswal Investment Advisors, Avendus Capital, HSBC Securities and Capital Markets (India), Nuvama Wealth Management |
Subscription status
| Category | Times subscribed |
|---|---|
| Non-institutional (NII) | 1.8x |
| Retail | 1.32x |
| Total | 1.34x |
As of 2026-10-19 11:30. Source: Moneycontrol, 19 Oct 2026, quoting NSE data as of 11:30 AM, day 3
Sahajanand Medical Technologies IPO GMP
| Date | GMP | Estimated listing price | Source |
|---|---|---|---|
| 19 Oct | ₹25 (+7.3%) | ₹369 | InvestorGain |
| 19 Oct | ₹25 (+7.3%) | ₹369 | NDTV Profit |
| 18 Oct | ₹15 (+4.4%) | ₹359 | ipomarket.in |
| 18 Oct | ₹20 (+5.8%) | ₹364 | InvestorGain |
| 18 Oct | ₹15 (+4.4%) | ₹359 | IPO Watch |
| 18 Oct | ₹22 (+6.4%) | ₹366 | Livemint |
| 17 Oct | ₹35 (+10.2%) | ₹379 | ipomarket.in |
| 17 Oct | ₹15 (+4.4%) | ₹359 | InvestorGain |
| 17 Oct | ₹15 (+4.4%) | ₹359 | IPO Watch |
| 16 Oct | ₹35 (+10.2%) | ₹379 | InvestorGain |
| 16 Oct | ₹40 (+11.6%) | ₹384 | IPO Watch |
| 16 Oct | ₹38 (+11.0%) | ₹382 | ipomarket.in |
| 15 Oct | ₹43 (+12.5%) | ₹387 | InvestorGain |
| 14 Oct | ₹41 (+11.9%) | ₹385 | InvestorGain |
| 13 Oct | ₹41 (+11.9%) | ₹385 | InvestorGain |
| 12 Oct | ₹35 (+10.2%) | ₹379 | InvestorGain |
| 11 Oct | ₹40 (+11.6%) | ₹384 | InvestorGain |
How to check Sahajanand Medical Technologies IPO allotment status
- Open the MUFG Intime India allotment page: in.mpms.mufg.com/Initial_Offer/public-issues.html.
- Pick Sahajanand Medical Technologies from the list (it appears on the evening of 21 Oct 2026), choose PAN and enter it.
- Or check on BSE or NSE. All the links
Questions
What is the Sahajanand Medical Technologies IPO GMP today?
The grey market premium was ₹25 on 19 Oct, which points to a listing price of about ₹369. GMP is unofficial and often wrong on listing day.
What is the price band and lot size of the Sahajanand Medical Technologies IPO?
The price band is ₹327 to ₹344 per share and one lot is 43 shares, so the minimum bid is ₹14,792.
When does the Sahajanand Medical Technologies IPO open and close?
It opens on 15 Oct 2026 and closes on 19 Oct 2026.
When is the Sahajanand Medical Technologies IPO allotment date?
Allotment is expected on 21 Oct 2026. Check it on the MUFG Intime India website or on BSE and NSE with your PAN.
When is the Sahajanand Medical Technologies IPO listing date?
Shares are expected to list on NSE and BSE on 23 Oct 2026.
Sources
- Offer document (RHP)
- NSE issue information: Sahajanand Medical Technologies (SMT)
- NSE: Sahajanand Medical Technologies RHP (dated October 9, 2026)
- SEBI: Sahajanand Medical Technologies Limited RHP
Employee reservation of up to 2,50,000 shares with no discount (NSE shows discount as NA).
Last updated 19 October 2026, 18:50 IST. Prices, dates and lot sizes are from each IPO's offer document and the stock exchanges; GMP readings name their source.
Saifu is not a SEBI-registered investment adviser or a broker. This page reports facts from the offer document, the stock exchanges and news reports, and the grey market premium as other sites report it. It is not a recommendation to apply for, buy or sell any share. Read the RHP and decide for yourself.
Spot a mistake on this page? Tell us